Stryker's Revenue in the fiscal year 2025 $ 25,116.00 millions
Stryker's Revenue in the fiscal year 2024 $ 22,595.00 millions
Stryker's Revenue in the fiscal year 2023 $ 20,498.00 millions
Stryker's Revenue in the fiscal year 2022 $ 18,449.00 millions
Stryker's Revenue in the fiscal year 2021 $ 17,108.00 millions
SYK Revenue second quarter 2026 Y/Y Growth Comment
Stryker Corp achieved in the second quarter 2026, above Company average Revenue improvement of 9.42% year on year, to $ 6,589.00 millions.
Looking into second quarter 2026 results within Medical Equipment & Supplies industry 94 other companies have achieved higher Revenue growth. While Stryker Corp' s Revenue increase of 9.42% ranks overall at the positon no. 1783 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Stryker's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
35.2 %
2.5 %
-22.97 %
(Sep 30 2020)
SYK's II. Quarter Q/Q Revenue Comment
Stryker Corp achieved in the II. Quarter 2026 above company average sequential Revenue increase of 9.45%, to $ 6,589.00 millions, from $6,020.00 millions in the first quarter. SYK is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 31 other companies have achieved higher Revenue quarter on quarter growth. While Stryker's Revenue growth quarter on quarter, overall rank is 827.
Stryker Corp achieved in the II. Quarter 2026 above company average sequential Revenue increase of 9.45%, to $ 6,589.00 millions, from $6,020.00 millions in the first quarter. SYK is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 31 other companies have achieved higher Revenue quarter on quarter growth. While Stryker's Revenue growth quarter on quarter, overall rank is 827.
Stryker's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 25,837.00
$ 25,270.00
$ 25,116.00
$ 24,381.00
$ 23,818.00
Y / Y Revenue Growth (TTM)
8.48 %
8.84 %
11.16 %
10.95 %
11.36 %
Year on Year Revenue Growth Overall
Ranking
# 1317
# 1101
# 931
# 781
# 1060
Seqeuential Revenue Change (TTM)
2.24 %
0.61 %
3.01 %
2.36 %
2.58 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2189
# 1855
# 1919
# 1926
# 1858
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Stryker's cumulative twelve months Revenue were $ 25,837 millions, company would post below average annual Revenue growth of 2.58% year on year, if the fiscal year would end at Jun 30 2026. A slow-down in the Stryker's Revenue growth from the 6020% growth in Mar 31 2026.
In the Healthcare sector 232 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1101 to 1317.
With the quarterly Revenue reported in the Jun 30 2026 period, Stryker's cumulative twelve months Revenue were $ 25,837 millions, company would post below average annual Revenue growth of -4.34% year on year, if the fiscal year would end at Jun 30 2026. A slow-down in the Stryker's Revenue growth from the 6020% growth in Mar 31 2026.
In the Healthcare sector 232 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1101 to 1317.
About Stryker Revenue Growth Rates (SYK), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
16.40%